186 related articles for article (PubMed ID: 26655944)
1. EBV Status and Thiopurine Use in Pediatric IBD.
Gordon J; Ramaswami A; Beuttler M; Jossen J; Pittman N; Lai J; Dunkin D; Benkov K; Dubinsky M
J Pediatr Gastroenterol Nutr; 2016 May; 62(5):711-4. PubMed ID: 26655944
[TBL] [Abstract][Full Text] [Related]
2. Impact of Epstein-Barr virus serological status on clinical outcomes in adult patients with inflammatory bowel disease.
de Francisco R; Castaño-García A; Martínez-González S; Pérez-Martínez I; González-Huerta AJ; Morais LR; Fernández-García MS; Jiménez S; Díaz-Coto S; Flórez-Díez P; Suárez A; Riestra S
Aliment Pharmacol Ther; 2018 Oct; 48(7):723-730. PubMed ID: 30095176
[TBL] [Abstract][Full Text] [Related]
3. Risk of malignant lymphoma in patients with inflammatory bowel diseases: a Dutch nationwide study.
Vos AC; Bakkal N; Minnee RC; Casparie MK; de Jong DJ; Dijkstra G; Stokkers P; van Bodegraven AA; Pierik M; van der Woude CJ; Oldenburg B; Hommes DW;
Inflamm Bowel Dis; 2011 Sep; 17(9):1837-45. PubMed ID: 21830262
[TBL] [Abstract][Full Text] [Related]
4. Multicenter, cross-sectional, observational study on Epstein-Barr viral infection status and thiopurine use by age group in patients with inflammatory bowel disease in Japan (EBISU study).
Miura M; Shimizu H; Saito D; Miyoshi J; Matsuura M; Kudo T; Hirayama D; Yoshida M; Arai K; Iwama I; Nakase H; Shimizu T; Hisamatsu T
J Gastroenterol; 2021 Dec; 56(12):1080-1091. PubMed ID: 34591171
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus in inflammatory bowel disease: the spectrum of intestinal lymphoproliferative disorders.
Nissen LH; Nagtegaal ID; de Jong DJ; Kievit W; Derikx LA; Groenen PJ; van Krieken JH; Hoentjen F
J Crohns Colitis; 2015 May; 9(5):398-403. PubMed ID: 25740811
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr Virus Status and Subsequent Thiopurine Exposure Within a Paediatric Inflammatory Bowel Disease Population.
Harris RE; Hegde V; Curtis L; Garrick V; Gervais L; Armstrong L; Delahunty C; Eccleston A; Al-Hourani G; Flynn DM; Merrick V; Barclay AR; Tayler R; Hansen R; Russell RK
J Pediatr Gastroenterol Nutr; 2021 Sep; 73(3):358-362. PubMed ID: 34091548
[TBL] [Abstract][Full Text] [Related]
7. Serologic Status of Routine Childhood Vaccines, Cytomegalovirus, and Epstein-Barr Virus in Children With Inflammatory Bowel Disease.
deBruyn JCC; Soon IS; Fonseca K; Feng S; Purtzki M; Goedhart C; Kuhn S; Vanderkooi OG; Wrobel I
Inflamm Bowel Dis; 2019 Jun; 25(7):1218-1226. PubMed ID: 30551205
[TBL] [Abstract][Full Text] [Related]
8. Lymphoma and other lymphoproliferative disorders in inflammatory bowel disease: a review.
Subramaniam K; D'Rozario J; Pavli P
J Gastroenterol Hepatol; 2013 Jan; 28(1):24-30. PubMed ID: 23094824
[TBL] [Abstract][Full Text] [Related]
9. Two rare cases of Epstein-Barr virus-associated lymphoproliferative disorders in inflammatory bowel disease patients on thiopurines and other immunosuppressive medications.
Subramaniam K; Cherian M; Jain S; Latimer M; Corbett M; D'Rozario J; Pavli P
Intern Med J; 2013 Dec; 43(12):1339-42. PubMed ID: 24330365
[TBL] [Abstract][Full Text] [Related]
10. The Status of Epstein-Barr Virus Infection in Intestinal Mucosa of Chinese Patients with Inflammatory Bowel Disease.
Li X; Chen N; You P; Peng T; Chen G; Wang J; Li J; Liu Y
Digestion; 2019; 99(2):126-132. PubMed ID: 30235444
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus in inflammatory bowel disease-correlation with different therapeutic regimens.
Magro F; Santos-Antunes J; Albuquerque A; Vilas-Boas F; Macedo GN; Nazareth N; Lopes S; Sobrinho-Simões J; Teixeira S; Dias CC; Cabral J; Sarmento A; Macedo G
Inflamm Bowel Dis; 2013 Jul; 19(8):1710-6. PubMed ID: 23574759
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of Epstein-Barr Virus, Cytomegalovirus, and Polyomaviruses in Children with Inflammatory Bowel Disease.
Hradsky O; Copova I; Zarubova K; Durilova M; Nevoral J; Maminak M; Hubacek P; Bronsky J
Dig Dis Sci; 2015 Nov; 60(11):3399-407. PubMed ID: 26091801
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppression for inflammatory bowel disease does not influence Epstein-Barr viral load in the short-term.
Rodríguez-Lago I; Merino O; López de Goicoechea MJ; Aranzamendi M; Zubiaurre L; Muro N; Ortiz de Zárate J; Cilla G; Cabriada JL
Gastroenterol Hepatol; 2019 Nov; 42(9):542-547. PubMed ID: 31402179
[TBL] [Abstract][Full Text] [Related]
14. Impact of Epstein-Barr virus infection in patients with inflammatory bowel disease.
Zhang H; Zhao S; Cao Z
Front Immunol; 2022; 13():1001055. PubMed ID: 36389673
[TBL] [Abstract][Full Text] [Related]
15. Human cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease: need for mucosal viral load measurement.
Ciccocioppo R; Racca F; Paolucci S; Campanini G; Pozzi L; Betti E; Riboni R; Vanoli A; Baldanti F; Corazza GR
World J Gastroenterol; 2015 Feb; 21(6):1915-26. PubMed ID: 25684960
[TBL] [Abstract][Full Text] [Related]
16. Anti-TNFα therapy for inflammatory bowel diseases is associated with Epstein-Barr virus lytic activation.
Lapsia S; Koganti S; Spadaro S; Rajapakse R; Chawla A; Bhaduri-McIntosh S
J Med Virol; 2016 Feb; 88(2):312-8. PubMed ID: 26307954
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine.
Dayharsh GA; Loftus EV; Sandborn WJ; Tremaine WJ; Zinsmeister AR; Witzig TE; Macon WR; Burgart LJ
Gastroenterology; 2002 Jan; 122(1):72-7. PubMed ID: 11781282
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and morbidity of Epstein-Barr virus infection in pediatric renal transplant recipients: a multicenter, prospective study.
Höcker B; Fickenscher H; Delecluse HJ; Böhm S; Küsters U; Schnitzler P; Pohl M; John U; Kemper MJ; Fehrenbach H; Wigger M; Holder M; Schröder M; Billing H; Fichtner A; Feneberg R; Sander A; Köpf-Shakib S; Süsal C; Tönshoff B
Clin Infect Dis; 2013 Jan; 56(1):84-92. PubMed ID: 23042966
[TBL] [Abstract][Full Text] [Related]
19. Association between Epstein-Barr virus seroconversion and immunohistochemical changes in tonsils of pediatric solid organ transplant recipients.
Shapiro NL; Tang CG; Bhattacharyya N
Laryngoscope; 2011 Aug; 121(8):1718-25. PubMed ID: 21792960
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Epstein-Barr Virus in a population of patients with inflammatory bowel disease: a prospective cohort study.
Linton MS; Kroeker K; Fedorak D; Dieleman L; Fedorak RN
Aliment Pharmacol Ther; 2013 Nov; 38(10):1248-54. PubMed ID: 24053733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]